Application of Chromatography for Point of Care Diagnosis of Noncommunicable Diseases

Abstract submission deadline

30 June 2025

Manuscript submission deadline

31 August 2025

Viewed by

5259

Topic Information

Dear Colleagues,

The diagnosis of non-communicable diseases typically involves a comprehensive approach that combines medical history, physical examination, laboratory tests, and imaging studies. Biomarker detection has emerged as a valuable diagnostic tool for specific diseases, but precise and rapid quantification of disease-specific biomarkers requires analytical methods that can enable fast sampling and preconcentration from sample matrices. Therefore, solid-phase extraction and micro-extraction techniques are gaining popularity in medical diagnosis due to their unique advantages, including integrated sampling, extraction, and analysis by GC-MS or LC-MS. This Special Issue focuses on the latest discoveries in the field of non-communicable disease diagnosis and aims to bring together clinical and primary researchers to submit interdisciplinary works on cutting-edge techniques, including sample preparation techniques and chromatography methods. The topic covers the latest progress in the development of point-of-care tests, molecular diagnostic tests, animal models for diseases, appropriate dosages and formulations, as well as artificial intelligence and machine learning predictive tools/models for the following diseases (but not limited to): 1. COPD 2. Stroke 3. Alzheimer's disease 4. Liver disease 5. Chronic kidney disease 6. Sickle cell disease/thalassemia 7. Cancer—breast, cervix, oral, and lung 8. Diabetes 9. Cardiovascular disease.

Dr. Chiranjit Ghosh
Dr. Liqin Chen
Prof. Dr. Keshava Balakrishna
Prof. Dr. Chiranjay Mukhopadhyay
Topic Editors

Keywords

Participating Journals

Journal Name	Impact Factor	CiteScore	Launched Year	First Decision (median)	APC
Analytica analytica	-	1.8	2020	17.9 Days	CHF 1000	Submit
Metabolites metabolites	3.5	5.7	2011	16.1 Days	CHF 2700	Submit
Separations separations	2.5	3.0	2014	15.1 Days	CHF 2600	Submit
Toxins toxins	3.9	7.5	2009	20.3 Days	CHF 2700	Submit
Molecules molecules	4.2	7.4	1996	15.1 Days	CHF 2700	Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (2 papers)

Order results

Content type Publication Date

Result details

Normal Extended Compact

Journals

All Analytica Metabolites Separations Toxins Molecules

Show export options expand_more Show export options expand_less

Select all

Export citation of selected articles as:

Plain Text BibTeX BibTeX (without abstracts) Endnote Endnote (without abstracts) Tab-delimited RIS

Error

Oops... you haven't selected anything for export.

Ok

clear

attachment

Supplementary material:
Supplementary File 1 (ZIP, 117 KiB)

14 pages, 583 KiB  

Open AccessReview

Metabolomic Insights into Attention Deficit Hyperactivity Disorder: A Scoping Review

by Maria Jose Muñoz-Zabaleta, Nicolás Garzón Rodríguez, Luis Eduardo Díaz-Barrera and Maria Fernanda Quiroz-Padilla

Metabolites 2025, 15(2), 133; https://doi.org/10.3390/metabo15020133 - 16 Feb 2025

Viewed by 926

Abstract

Background /Objectives Attention deficit hyperactivity disorder (ADHD) is the most common neurodevelopmental condition, and symptoms persist into adulthood. Its etiology, though recognized as multifactorial, is still under discussion. Metabolomics helps us to identify pathways associated with functional and structural changes that may be [...] Read more.

Background /Objectives Attention deficit hyperactivity disorder (ADHD) is the most common neurodevelopmental condition, and symptoms persist into adulthood. Its etiology, though recognized as multifactorial, is still under discussion. Metabolomics helps us to identify pathways associated with functional and structural changes that may be related to symptomatology. This study aimed to characterize potentially altered metabolic pathways and associated biochemical reactions in ADHD. Methods: A scoping review of experimental research was conducted using PubMed, Web of Science, and Scopus using PRISMA ScR. Fifty-five studies were eligible for data extraction, of which fifteen met the criteria for inclusion in the review. Subsequently, the identified metabolites were analyzed in the context of the literature to recognize possible discordant pathways in the disorder. Results: Two groups of relevant neuromodulators of ADHD were found: precursors of monoamines and polyunsaturated fatty acids. The literature was reviewed to discover potential implicated pathways and new metabolites of interest. Conclusions: The study of ADHD biomarkers should focus on measuring precursor, intermediate, and final metabolites of polyunsaturated fatty acids and monoamines in panels or through untargeted analysis to improve the understanding of the pathology and individualization of treatments. Full article

(This article belongs to the Topic Application of Chromatography for Point of Care Diagnosis of Noncommunicable Diseases)

►▼ Show Figures

Figure 1

attachment

Supplementary material:
Supplementary File 1 (ZIP, 603 KiB)

18 pages, 3284 KiB  

Open AccessArticle

Screening and Application of DNA Aptamers for Heparin-Binding Protein

by Xi Zhou, Yingying Cao, Xiaocui Huang, Shuqian Qiu, Xinran Xiang, Huimin Niu, Li Chen, Shuiliang Wang, Zhenyu Lin and Shenghang Zhang

Molecules 2024, 29(8), 1717; https://doi.org/10.3390/molecules29081717 - 10 Apr 2024

Viewed by 2380

Abstract

Rapid detection of heparin-binding protein (HBP) is essential for timely intervention in sepsis cases. Current detection techniques are usually antibody-based immunological methods, which have certain problems, such as complexity and slow detection, and fall short in meeting the urgency of clinical needs. The [...] Read more.

Rapid detection of heparin-binding protein (HBP) is essential for timely intervention in sepsis cases. Current detection techniques are usually antibody-based immunological methods, which have certain problems, such as complexity and slow detection, and fall short in meeting the urgency of clinical needs. The application of an aptamer can address these concerns well. In this study, HBP-specific DNA aptamers were screened first. Among which, Apt-01, Apt−02, and Apt−13 had a high affinity for HBP, exhibiting impressive K_D values of 3.42, 1.44, and 1.04 nmol/L, respectively. Then, the aptamer of HBP and its partially complementary primer probe were combined to form double-stranded DNA (dsDNA) and synthesize a circular DNA template. The template is complementary to the primer probe, but due to the presence of dsDNA, ExoIII cleaves C2-13 as an RCA primer probe, rendering the template unable to recognize the primer probe and preventing the RCA reaction from proceeding. When the target is present, it competes with the adapter for recognition and releases C2-13, exposing its 3′ end. After initiating the RCA at room temperature and reacting with SYBR GreenII at 37 °C for 20 min, fluorescence changes can be observed and quantitatively analyzed at a 530 nm wavelength, achieving quantitative biological analysis. Apt-01 was used to develop a fluorescent biosensor for HBP detection, which exhibited a good linear range (0.01 nmol/L to 10 nmol/L) and detection limit (0.0056 nmol/L). This advancement holds the potential to lay a solid groundwork for pioneering sensitive and specific methods for HBP detection and to significantly enhance the diagnostic processes for sepsis. Full article

(This article belongs to the Topic Application of Chromatography for Point of Care Diagnosis of Noncommunicable Diseases)

►▼ Show Figures

Graphical abstract

Show export options expand_more Show export options expand_less

Select all

Export citation of selected articles as:

Plain Text BibTeX BibTeX (without abstracts) Endnote Endnote (without abstracts) Tab-delimited RIS

 

Error

Oops... you haven't selected anything for export.

Ok

clear

Displaying articles 1-2